Association between normal-weight central obesity and cardiometabolic disorders: a longitudinal analysis from health check-up data.
- 1Center for Health Management, Jiangsu Province Geriatric Hospital, 2 Yi-He Road, Nanjing, 210009, China.
- 2Center for Health Management, Jiangsu Province Geriatric Hospital, 2 Yi-He Road, Nanjing, 210009, China. [email protected].
- 3Center for Health Management, Jiangsu Province Geriatric Hospital, 2 Yi-He Road, Nanjing, 210009, China. [email protected].
Abstract
Background
Although several cross-sectional studies have examined the relationship between normal-weight central obesity (NWCO) and the risk of cardiometabolic disorders (CMD), longitudinal evidence from cohort studies is still limited, especially regarding diverse CMD outcomes in Chinese populations.Methods
We conducted a retrospective cohort study by using health examination records from Jiangsu Province Geriatric Hospital. The study included 5,606 normal-weight (body mass index of 18.0-24.0 kg/m²) participants free of CMD at their baseline visit in 2022. NWCO was defined as normal-weight and central obesity (waist circumference ≥ 90 cm for men or ≥ 80 cm for women), whereas normal-weight non-central obesity (NWNO) was defined as normal-weight without central obesity. Participants were followed until the occurrence incident CMD events or the last visit in 2024. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for CMD and its related components.Results
Among all participants (median age 40 years), 388 (6.9%) had NWCO. During a mean follow-up of 1.98[Formula: see text]0.18 years, NWCO was associated with a greater risk for CMD (HR: 1.39, 95% CI: 1.13-1.71) compared with NWNO group. Similar risk elevations were observed for CMD components, including hypertension (HTN), diabetes mellitus (DM) and hyperlipidemia (HLP).Conclusion
Our analysis of a longitudinal health check-up database demonstrated the potential impact of NWCO on the risk for CMD, confirming the importance of abdominal obesity in the development of CMD even in normal-weight individuals.
Related
- Cardiometabolic Risk Factors, Obesity Phenotypes, and Novel Anthropometric Indices in Patients With Acute Coronary Syndrome: A Hospital-Based Case-Control Study in Central India
- Role of Physical Activity in Obesity Treatment and Cardiometabolic Health: A Scientific Statement From the American Heart Association
- Association between parental cardiometabolic risk and longitudinal weight velocity in rural Indian children
- Cardiometabolic therapy for rhythm control: a case report of refractory atrial fibrillation resolving after initiation of semaglutide for obesity
- Beyond BMI: The Role of Visceral Adipose Tissue in Cardiometabolic Risk Stratification Among Children and Adolescents with Obesity—A Systematic Review
BibTeX
@article{cheng2026association,
title = {{Association between normal-weight central obesity and cardiometabolic disorders: a longitudinal analysis from health check-up data.}},
author = {Yang Cheng and Hui Zheng and Hongli Yin and Donghua Yin and Hui Wang and Ying Wang},
journal = {BMC cardiovascular disorders},
year = {2026},
month = jul,
doi = {10.1186/s12872-026-06323-5},
url = {https://europepmc.org/article/MED/42902148},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Association between normal-weight central obesity and cardiometabolic disorders: a longitudinal analysis from health check-up data.
AU - Yang Cheng
AU - Hui Zheng
AU - Hongli Yin
AU - Donghua Yin
AU - Hui Wang
AU - Ying Wang
PY - 2026
DA - 2026/07/01
JO - BMC cardiovascular disorders
DO - 10.1186/s12872-026-06323-5
UR - https://europepmc.org/article/MED/42902148
AB - Background Although several cross-sectional studies have examined the relationship between normal-weight central obesity (NWCO) and the risk of cardiometabolic disorders (CMD), longitudinal evidence from cohort studies is still limited, especially regarding diverse CMD outcomes in Chinese populations.Methods We conducted a retrospective cohort study by using health examination records from Jiangsu Province Geriatric Hospital. The study included 5,606 normal-weight (body mass index of 18.0-24.0 kg/m²) participants free of CMD at their baseline visit in 2022. NWCO was defined as normal-weight and central obesity (waist circumference ≥ 90 cm for men or ≥ 80 cm for women), whereas normal-weight non-central obesity (NWNO) was defined as normal-weight without central obesity. Participants were followed until the occurrence incident CMD events or the last visit in 2024. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for CMD and its related components.Results Among all participants (median age 40 years), 388 (6.9%) had NWCO. During a mean follow-up of 1.98[Formula: see text]0.18 years, NWCO was associated with a greater risk for CMD (HR: 1.39, 95% CI: 1.13-1.71) compared with NWNO group. Similar risk elevations were observed for CMD components, including hypertension (HTN), diabetes mellitus (DM) and hyperlipidemia (HLP).Conclusion Our analysis of a longitudinal health check-up database demonstrated the potential impact of NWCO on the risk for CMD, confirming the importance of abdominal obesity in the development of CMD even in normal-weight individuals.
SN - 1471-2261
ER -